Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI protocol, and 90% specificity. Medscape Medical News
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Calculator Aids With Assessing SNL Metastasis Risk in Melanoma
The risk calculator shows improved precision in a population larger than the original dataset used to validate the tool. Medscape Medical News
-
Running the ED Like a Pro: Your Residency Playbook
Drs Glatter and Ho share essential tips, time-saving hacks, and team-first strategies to help emergency medicine residents thrive from day one in the emergency department. Medscape Emergency Medicine
-
Few Patients With Diastolic Dysfunction Progress to HFpEF
Only a small proportion of patients with preclinical left ventricular diastolic dysfunction develop HFpEF over time, with blood pressure and kidney function influencing marker levels. Medscape News UK
-
Pain Relief With Linzagolix in UFs: PRIMROSE Trials
Pain reduction with linzagolix for uterine fibroids is partly explained by reduced heavy menstrual bleeding and fibroid volume in a pooled analysis. Medscape News UK
-
Is a Year of DAPT Magical Thinking?
The need for 12 months of dual antiplatelet therapy after coronary stenting has become entrenched in practice despite little supporting evidence, writes cardiologist Chris Labos. theheart.org on Medscape
-
Oral Cavity Cancer: Omitting Neck RT Safe in Some Patients
Skipping postoperative neck irradiation in patients with oral cavity carcinoma yields control rates similar to those in patients who receive both neck and primary tumor radiation. Medscape Medical News
-
Anal Cancer Outcomes Improve on Lower-Dose Chemoradiotherapy
Short-term results from a recent trial suggest that reduced-dose chemoradiotherapy may achieve high local control with less toxicity in patients with early-stage anal cancer. Medscape Medical News
-
Thyroid Cancer Incidence Unchanged After RAIT Therapy
Research found no significant increase in the incidence of new thyroid cancer cases among patients treated with RAIT for Graves’ disease, reinforcing previous studies that suggest minimal cancer risk with this treatment. Medscape Medical News
-
New Model Predicts Risk for Progression of RA-ILD
A novel model incorporating clinical factors and levels of several biomarkers, including those indicating pulmonary damage, successfully identifies patients with RA-ILD at a high risk for progression. Medscape Medical News